netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Results

Looking for Cetuximab found 10 matches
Open monograph to display formulary status BNF Category
  Cetuximab Malignant disease and immunosuppression - Cetuximab - 08.01.05
  Cytotoxic Drug Encorafenib  (Braftovi®) Malignant disease and immunosuppression - Protein kinase inhibitors - 08.01.05
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section MHRA Drug Safety Update (Feb 2014): Cetuximab: new safety information available (08.01.05)
link in drug section NICE TA145: Cetuximab for the treatment of locally advanced squamous cell cancer of the head and neck (08.01.05)
link in drug section NICE TA242: Cetuximab for the treatment of metastatic colorectal cancer after first-line chemotherapy: monotherapy or combination chemotherapy (08.01.05)
link in drug section NICE TA439 Cetuximab and panitumumab for previously untreated metastatic colorectal cancer (08.01.05)
link in drug section NICE TA439 Cetuximab and panitumumab for previously untreated metastatic colorectal cancer (08.01.05)
link in drug section NICE TA473 Cetuximab for treating recurrent or metastatic squamous cell cancer of the head and neck (oral cavity) (08.01.05)
link in drug section NICE TA668: Encorafenib plus cetuximab for previously treated BRAF V600E mutation-positive metastatic colorectal cancer (08.01.05)

SubSection Titles / notes  
Cetuximab - (08.01.05)

 
netFormulary